EXHIBIT 32.0
Published on November 14, 2008
Exhibit
32.0
CERTIFICATION
PURSUANT TO
EXCHANGE
ACT RULE 13(a)-14(b) AND 18 U.S.C. SECTION 1350
In
connection with the report of Rexahn Pharmaceuticals, Inc. (the “Company”) on
Form 10-Q for the period ended September 30, 2008, as filed with the Securities
and Exchange Commission on the date hereof (the “Report”), and pursuant to
Exchange Act Rule 13(a)-14(b) and 18 U.S.C. Section 1350, each of the
undersigned officers of the Company does hereby certify that, to the best of
such officer’s knowledge:
|
(1)
|
The Report fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act
of 1934; and
|
|
(2)
|
The information contained in the
Report fairly presents, in all material respects, the financial condition
and results of operations of the
Company.
|
The
undersigned have executed this Certificate as of the 14th day of November
2008.
|
/s/ Chang H. Ahn
|
||
|
Chang
H. Ahn
|
||
|
Chief
Executive Officer
|
||
|
/s/ Ted T.H. Jeong
|
||
|
Ted
T.H. Jeong
|
||
|
Chief
Financial Officer
|
||